Evidence map›Paper›PMID 42246067›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Why Andes hantavirus is not the next SARS-CoV-2: contrasting viral shedding, transmissibility and genomic patterns.

Antonin Bal, Virginie Sauvage, Maude Bouscambert-Duchamp, Bruno Lina, Alexandre Gaymard, Jean-Claude Manuguerra

Erratum issuedAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Antonin BalHospices Civils de Lyon (HCL), Centre National de Référence des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.
Virginie SauvageInstitut Pasteur, Université Paris Cité, Environment and Infectious Risk Research Unit, French National Reference Centre for Hantaviruses, Paris, France.
Maude Bouscambert-DuchampHospices Civils de Lyon (HCL), Centre National de Référence des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.
Bruno LinaHospices Civils de Lyon (HCL), Centre National de Référence des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.
Alexandre GaymardHospices Civils de Lyon (HCL), Centre National de Référence des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.
Jean-Claude ManuguerraInstitut Pasteur, Université Paris Cité, Environment and Infectious Risk Research Unit, French National Reference Centre for Hantaviruses, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A cruise ship-associated Andes hantavirus outbreak has raised questions usually associated with respiratory viruses, including transmissibility and pandemic risk. Although Andes virus may enter through the respiratory route, cause severe respiratory disease and under close contact spread between humans, it differs fundamentally from SARS-CoV-2. The ecology is rodent-borne, pathogenesis is vascular, diagnosis is centred on blood PCR and serology, and genetic diversity is mainly shaped by reservoir ecology and geography rather than by sustained human-to-human transmission and immune selection.

Indexed as

Hantavirus InfectionsOrthohantavirusVirus SheddingAnimalsCOVID-19Genome, ViralHumansPandemicsSARS-CoV-2ShipsDiagnosticHantavirusSARS-CoV-2TransmissibilityViral Shedding

Identifiers

PMID42246067
PMCPMC13241791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.